If one were to anthropomorphize the NIH’s genome institute (no, I don’t know why you would, but humor me for a second), it would be a millennial, who at 29, was probably, finally, starting to get the hang of adulting.
So now what?
The institute, formally called the National Human Genome Research Institute, part of the National Institutes of Health, announced recently that it is undergoing a new round of strategic planning—a process it expects to finalize in October 2020—to determine how to expand the field of genomics to foster new medical breakthroughs.
It’s calling it a “2020 vision.” … I see what you did there, NHGRI … I see you.
“We are trying to write a clear vision for using genomics to advance human health and we’re using the process to guide our scientific priorities and to shape our research portfolio as well as foster new partnerships,” Cristina Kapustij, chief of policy and program analysis at the institute, said at the HL7 genomics conference I attended earlier this week.
Why are they doing this? When the NIH established the National Center for Human Genome Research in 1989 (it became the NHGRI in 1997), genomics was an emerging field. Now it’s embedded into every field of research from cancer to diabetes to vision loss.
“Everyone has a little piece of genomics,” said Kapustij, an evolution of research she described as fantastic and successful. “Now that genomics is so ubiquitous and it’s been incorporated into so many aspects, the institute has to re-evaluate what our role is in this space.”
The NHGRI is currently accepting comments online about the strategic plan and also will organize town halls across the country and hold events at scientific meetings to solicit input. And of course, there’s a hashtag: #Genomics2020.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)